These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8523355)
1. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. Yeh LA; Augustine AJ; Lee P; Riviere LR; Sheldon A J Rheumatol; 1995 Sep; 22(9):1740-6. PubMed ID: 8523355 [TBL] [Abstract][Full Text] [Related]
2. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643 [TBL] [Abstract][Full Text] [Related]
3. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045 [TBL] [Abstract][Full Text] [Related]
4. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants. Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406 [TBL] [Abstract][Full Text] [Related]
5. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Morris EA; Wilcon S; Treadwell BV Am J Vet Res; 1992 Nov; 53(11):1977-82. PubMed ID: 1466488 [TBL] [Abstract][Full Text] [Related]
7. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. Chan PS; Caron JP; Orth MW J Rheumatol; 2006 Jul; 33(7):1329-40. PubMed ID: 16821268 [TBL] [Abstract][Full Text] [Related]
8. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558 [TBL] [Abstract][Full Text] [Related]
9. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Homandberg GA; Hui F Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407 [TBL] [Abstract][Full Text] [Related]
10. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor. Alsalameh S; Mattka B; Al-Ward R; Lorenz HM; Manger B; Pfizenmaier K; Grell M; Kalden JR J Rheumatol; 1999 Mar; 26(3):645-53. PubMed ID: 10090177 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown. Cai L; Suboc P; Hogue DA; Fei DT; Filvaroff EH J Rheumatol; 2002 Aug; 29(8):1725-36. PubMed ID: 12180737 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [TBL] [Abstract][Full Text] [Related]
13. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Hardingham TE; Bayliss MT; Rayan V; Noble DP Br J Rheumatol; 1992; 31 Suppl 1():1-6. PubMed ID: 1532522 [TBL] [Abstract][Full Text] [Related]
14. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes. Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219 [TBL] [Abstract][Full Text] [Related]
15. Production of cytokines by chondrocytes and its role in proteoglycan degradation. Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138 [TBL] [Abstract][Full Text] [Related]
16. The role of cytokines in osteoarthritis pathophysiology. Fernandes JC; Martel-Pelletier J; Pelletier JP Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6. Lazarus DD; Moldawer LL; Lowry SF Lymphokine Cytokine Res; 1993 Aug; 12(4):219-23. PubMed ID: 8218594 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit. Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769 [TBL] [Abstract][Full Text] [Related]
19. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats. Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158 [TBL] [Abstract][Full Text] [Related]
20. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]